POINT BIOPHARMA GLOBAL INC. Interest Costs Capitalized
POINT BIOPHARMA GLOBAL INC. reported Interest Costs Capitalized of $63.20 thousand for the 12-month period ending 2021-12-31, per its 10-K filed 2023-03-27.
Discontinued › Expense Statement › Operating Expenses
us-gaap:InterestCostsCapitalized · last filed 2023-03-27
- POINT BIOPHARMA GLOBAL INC. interest costs capitalized for the quarter ending 2021-12-31 was $0.00.
- POINT BIOPHARMA GLOBAL INC. interest costs capitalized for the quarter ending 2021-09-30 was $8.59K, a 66.26% decline year-over-year.
- POINT BIOPHARMA GLOBAL INC. interest costs capitalized for the quarter ending 2021-06-30 was $27.92K.
- POINT BIOPHARMA GLOBAL INC. interest costs capitalized for the quarter ending 2021-03-31 was $26.69K.
- POINT BIOPHARMA GLOBAL INC. interest costs capitalized for fiscal 2021 was $63.20K, a 15.73% increase from fiscal 2020.
- POINT BIOPHARMA GLOBAL INC. interest costs capitalized for fiscal 2020 was $54.60K.
| Period end | Interest Costs Capitalized 3 month | Interest Costs Capitalized 6 month | Interest Costs Capitalized 9 month | Interest Costs Capitalized 12 month |
|---|---|---|---|---|
| 2021-12-31 | $0.00 derived: 10-K 12 month − 10-Q 9 month · filed 2023-03-27 | $8.59K derived: sum of 2 quarters · filed 2023-03-27 | $36.51K derived: sum of 3 quarters · filed 2023-03-27 | $63.20K 10-K · filed 2023-03-27 |
| 2021-09-30 | $8.59K 10-Q · filed 2022-11-14 | $36.51K derived: sum of 2 quarters · filed 2022-11-14 | $63.20K 10-Q · filed 2022-11-14 | |
| 2021-06-30 | $27.92K 10-Q · filed 2022-08-12 | $54.60K 10-Q · filed 2022-08-12 | ||
| 2021-03-31 | $26.69K 10-Q · filed 2022-05-13 | |||
| 2020-12-31 | $54.60K 10-K · filed 2022-03-25 | |||
| 2020-09-30 | $25.46K 10-Q · filed 2021-11-12 | |||
| 2020-06-30 | $0.00 10-Q · filed 2021-08-13 |